Evaxion Biotech's total assets for Q3 2024 were $15.19M, a decrease of -0.30% from the previous quarter. EVAX total liabilities were $15.19M for the fiscal quarter, a 8.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.